HEADER HYDROLASE/IMMUNE SYSTEM 31-OCT-22 8EZ3 TITLE STRUCTURE OF 3A10 FAB IN COMPLEX WITH A/MOSCOW/10/1999 (H3N2) TITLE 2 INFLUENZA VIRUS NEURAMINIDASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAVY CHAIN OF INFLUENZA VIRUS NEURAMINIDASE ANTIBODY 3A10; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN OF INFLUENZA VIRUS NEURAMINIDASE ANTIBODY 3A10; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: NEURAMINIDASE; COMPND 11 CHAIN: A; COMPND 12 EC: 3.2.1.18; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 11 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS (A/MOSCOW/10/1999(H3N2)); SOURCE 15 ORGANISM_TAXID: 480019; SOURCE 16 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS ANTIBODY, NEURAMINIDASE, INFLUENZA, HYDROLASE-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Z.MOU,R.LEI,N.C.WU,X.DAI REVDAT 4 13-NOV-24 8EZ3 1 REMARK REVDAT 3 01-MAY-24 8EZ3 1 JRNL REVDAT 2 22-NOV-23 8EZ3 1 JRNL REVDAT 1 08-NOV-23 8EZ3 0 JRNL AUTH R.LEI,W.KIM,H.LV,Z.MOU,M.J.SCHERM,A.J.SCHMITZ,J.S.TURNER, JRNL AUTH 2 T.J.C.TAN,Y.WANG,W.O.OUYANG,W.LIANG,J.RIVERA-CARDONA,C.TEO, JRNL AUTH 3 C.S.GRAHAM,C.B.BROOKE,R.M.PRESTI,C.K.P.MOK,F.KRAMMER,X.DAI, JRNL AUTH 4 A.H.ELLEBEDY,N.C.WU JRNL TITL LEVERAGING VACCINATION-INDUCED PROTECTIVE ANTIBODIES TO JRNL TITL 2 DEFINE CONSERVED EPITOPES ON INFLUENZA N2 NEURAMINIDASE. JRNL REF IMMUNITY V. 56 2621 2023 JRNL REFN ISSN 1074-7613 JRNL PMID 37967533 JRNL DOI 10.1016/J.IMMUNI.2023.10.005 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.500 REMARK 3 NUMBER OF PARTICLES : 216485 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING ONLY REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8EZ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1000269659. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : STRUCTURE OF 3A10 FAB IN REMARK 245 COMPLEX WITH A/MOSCOW/10/1999 REMARK 245 (H3N2) INFLUENZA VIRUS REMARK 245 NEURAMINIDASE REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : STRUCTURE OF 3A10 FAB IN REMARK 245 COMPLEX WITH A/MOSCOW/10/1999 (H3N2) INFLUENZA VIRUS REMARK 245 NEURAMINIDASE REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA L 64 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE ARG A 403 OE1 GLN A 432 2.08 REMARK 500 OG SER A 331 O7 NAG A 503 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 417 CA - CB - SG ANGL. DEV. = 13.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER L 26 -168.73 -161.29 REMARK 500 SER L 27A 36.32 -97.86 REMARK 500 ASN L 27B -154.24 -148.70 REMARK 500 ASN L 51 -17.05 70.98 REMARK 500 SER L 52 93.68 -165.14 REMARK 500 ASN L 53 49.51 -148.69 REMARK 500 ARG L 54 113.11 -39.59 REMARK 500 SER L 56 141.64 -173.00 REMARK 500 GLU L 81 -0.14 78.19 REMARK 500 SER A 88 30.17 -91.98 REMARK 500 LYS A 221 -168.27 -126.94 REMARK 500 LYS A 296 -31.01 -131.69 REMARK 500 CYS A 337 -6.57 72.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MAN A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-28728 RELATED DB: EMDB REMARK 900 STRUCTURE OF 3A10 FAB IN COMPLEX WITH A/MOSCOW/10/1999 (H3N2) REMARK 900 INFLUENZA VIRUS NEURAMINIDASE DBREF 8EZ3 H 1 113 PDB 8EZ3 8EZ3 1 113 DBREF 8EZ3 L 2 106A PDB 8EZ3 8EZ3 2 106 DBREF 8EZ3 A 82 469 UNP Q8AZ87 Q8AZ87_9INFA 82 469 SEQRES 1 H 123 GLN VAL GLN LEU GLN GLU SER GLY PRO GLY LEU VAL ARG SEQRES 2 H 123 PRO SER GLN THR LEU SER LEU THR CYS THR VAL SER GLY SEQRES 3 H 123 ALA SER ILE SER ASP VAL ASP PHE TYR TRP THR TRP PHE SEQRES 4 H 123 ARG GLN THR PRO GLY LYS GLY LEU GLU TRP ILE GLY TYR SEQRES 5 H 123 THR ASN SER ILE GLY ASN ALA PHE TYR ASN PRO SER LEU SEQRES 6 H 123 GLN SER ARG LEU THR ILE SER ILE ASP THR SER ASP ASN SEQRES 7 H 123 HIS PHE SER LEU ARG LEU LYS SER VAL THR ALA ALA ASP SEQRES 8 H 123 THR ALA VAL TYR TYR CYS ALA ARG SER ASN SER ASN THR SEQRES 9 H 123 TRP SER ARG GLU TYR PHE GLN HIS TRP GLY GLN GLY THR SEQRES 10 H 123 LEU VAL THR VAL SER SER SEQRES 1 L 111 SER VAL LEU THR GLN PRO PRO SER VAL SER GLY ALA PRO SEQRES 2 L 111 GLY GLN ARG VAL SER ILE SER CYS THR GLY SER SER SER SEQRES 3 L 111 ASN ILE GLY ALA GLY PHE ASP VAL HIS TRP TYR GLN GLN SEQRES 4 L 111 VAL PRO GLY THR ALA PRO LYS LEU LEU ILE TYR GLY ASN SEQRES 5 L 111 SER ASN ARG PRO SER GLY VAL PRO ASP ARG PHE SER ALA SEQRES 6 L 111 SER LYS SER GLY THR SER ALA SER LEU ALA ILE THR GLY SEQRES 7 L 111 LEU GLN PRO GLU ASP GLU ALA ASP TYR TYR CYS GLN SER SEQRES 8 L 111 TYR ASP ASN SER LEU SER VAL ASN TYR VAL PHE GLY THR SEQRES 9 L 111 GLY THR ARG VAL THR VAL LEU SEQRES 1 A 388 ALA GLU TYR ARG ASN TRP SER LYS PRO GLN CYS ASN ILE SEQRES 2 A 388 THR GLY PHE ALA PRO PHE SER LYS ASP ASN SER ILE ARG SEQRES 3 A 388 LEU SER ALA GLY GLY ASP ILE TRP VAL THR ARG GLU PRO SEQRES 4 A 388 TYR VAL SER CYS ASP PRO ASP LYS CYS TYR GLN PHE ALA SEQRES 5 A 388 LEU GLY GLN GLY THR THR LEU ASN ASN GLY HIS SER ASN SEQRES 6 A 388 ASP THR VAL HIS ASP ARG THR PRO TYR ARG THR LEU LEU SEQRES 7 A 388 MET ASN GLU LEU GLY VAL PRO PHE HIS LEU GLY THR LYS SEQRES 8 A 388 GLN VAL CYS ILE ALA TRP SER SER SER SER CYS HIS ASP SEQRES 9 A 388 GLY LYS ALA TRP LEU HIS VAL CYS VAL THR GLY ASP ASP SEQRES 10 A 388 GLU ASN ALA THR ALA SER PHE ILE TYR ASN GLY ARG LEU SEQRES 11 A 388 VAL ASP SER ILE GLY SER TRP SER LYS LYS ILE LEU ARG SEQRES 12 A 388 THR GLN GLU SER GLU CYS VAL CYS ILE ASN GLY THR CYS SEQRES 13 A 388 THR VAL VAL MET THR ASP GLY SER ALA SER GLY LYS ALA SEQRES 14 A 388 ASP THR LYS ILE LEU PHE ILE GLU GLU GLY LYS ILE VAL SEQRES 15 A 388 HIS THR SER PRO LEU SER GLY SER ALA GLN HIS VAL GLU SEQRES 16 A 388 GLU CYS SER CYS TYR PRO ARG TYR PRO GLY VAL ARG CYS SEQRES 17 A 388 VAL CYS ARG ASP ASN TRP LYS GLY SER ASN ARG PRO ILE SEQRES 18 A 388 VAL ASP ILE ASN VAL LYS ASP TYR SER ILE VAL SER SER SEQRES 19 A 388 TYR VAL CYS SER GLY LEU VAL GLY ASP THR PRO ARG LYS SEQRES 20 A 388 ASN ASP SER SER SER SER SER HIS CYS LEU ASP PRO ASN SEQRES 21 A 388 ASN GLU GLU GLY GLY HIS GLY VAL LYS GLY TRP ALA PHE SEQRES 22 A 388 ASP ASP GLY ASN ASP VAL TRP MET GLY ARG THR ILE SER SEQRES 23 A 388 GLU LYS LEU ARG SER GLY TYR GLU THR PHE LYS VAL ILE SEQRES 24 A 388 GLU GLY TRP SER LYS PRO ASN SER LYS LEU GLN ILE ASN SEQRES 25 A 388 ARG GLN VAL ILE VAL ASP ARG GLY ASN ARG SER GLY TYR SEQRES 26 A 388 SER GLY ILE PHE SER VAL GLU GLY LYS SER CYS ILE ASN SEQRES 27 A 388 ARG CYS PHE TYR VAL GLU LEU ILE ARG GLY ARG LYS GLN SEQRES 28 A 388 GLU THR GLU VAL LEU TRP THR SER ASN SER ILE VAL VAL SEQRES 29 A 388 PHE CYS GLY THR SER GLY THR TYR GLY THR GLY SER TRP SEQRES 30 A 388 PRO ASP GLY ALA ASP ILE ASN LEU MET PRO ILE HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET MAN B 5 11 HET MAN A 501 11 HET NAG A 502 14 HET NAG A 503 14 HET NAG A 504 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 4 NAG 5(C8 H15 N O6) FORMUL 4 BMA C6 H12 O6 FORMUL 4 MAN 3(C6 H12 O6) HELIX 1 AA1 ASN L 27B GLY L 30 5 5 HELIX 2 AA2 ASN A 104 ALA A 110 1 7 HELIX 3 AA3 ASN A 142 ASN A 146 5 5 HELIX 4 AA4 ASP A 463 MET A 467 5 5 SHEET 1 AA1 4 GLN H 3 SER H 7 0 SHEET 2 AA1 4 LEU H 18 SER H 25 -1 O SER H 25 N GLN H 3 SHEET 3 AA1 4 HIS H 77 LEU H 82 -1 O PHE H 78 N CYS H 22 SHEET 4 AA1 4 ILE H 69 ASP H 72 -1 N ASP H 72 O HIS H 77 SHEET 1 AA2 5 LEU H 11 VAL H 12 0 SHEET 2 AA2 5 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 AA2 5 ALA H 88 ARG H 94 -1 N TYR H 90 O THR H 107 SHEET 4 AA2 5 TRP H 35A GLN H 39 -1 N PHE H 37 O TYR H 91 SHEET 5 AA2 5 LEU H 45 GLY H 49 -1 O ILE H 48 N TRP H 36 SHEET 1 AA3 4 LEU H 11 VAL H 12 0 SHEET 2 AA3 4 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 AA3 4 ALA H 88 ARG H 94 -1 N TYR H 90 O THR H 107 SHEET 4 AA3 4 HIS H 102 TRP H 103 -1 O HIS H 102 N ARG H 94 SHEET 1 AA4 5 SER L 9 SER L 12 0 SHEET 2 AA4 5 THR L 102 THR L 105 1 O ARG L 103 N VAL L 11 SHEET 3 AA4 5 ASP L 85 ASP L 92 -1 N TYR L 86 O THR L 102 SHEET 4 AA4 5 VAL L 33 GLN L 38 -1 N HIS L 34 O GLN L 89 SHEET 5 AA4 5 LYS L 45 ILE L 48 -1 O LYS L 45 N GLN L 37 SHEET 1 AA5 4 SER L 9 SER L 12 0 SHEET 2 AA5 4 THR L 102 THR L 105 1 O ARG L 103 N VAL L 11 SHEET 3 AA5 4 ASP L 85 ASP L 92 -1 N TYR L 86 O THR L 102 SHEET 4 AA5 4 ASN L 95C PHE L 98 -1 O ASN L 95C N ASP L 92 SHEET 1 AA6 3 ARG L 18 THR L 24 0 SHEET 2 AA6 3 SER L 70 THR L 76 -1 O ALA L 71 N CYS L 23 SHEET 3 AA6 3 PHE L 62 SER L 67 -1 N SER L 63 O ALA L 74 SHEET 1 AA7 4 GLY A 96 LYS A 102 0 SHEET 2 AA7 4 THR A 439 THR A 449 -1 O THR A 449 N GLY A 96 SHEET 3 AA7 4 ILE A 418 GLY A 429 -1 N PHE A 422 O PHE A 446 SHEET 4 AA7 4 SER A 407 GLU A 413 -1 N PHE A 410 O CYS A 421 SHEET 1 AA8 4 TRP A 115 CYS A 124 0 SHEET 2 AA8 4 CYS A 129 THR A 139 -1 O TYR A 130 N SER A 123 SHEET 3 AA8 4 THR A 157 GLU A 162 -1 O ASN A 161 N GLN A 131 SHEET 4 AA8 4 LYS A 172 ILE A 176 -1 O CYS A 175 N LEU A 158 SHEET 1 AA9 4 SER A 179 HIS A 184 0 SHEET 2 AA9 4 TRP A 189 THR A 195 -1 O VAL A 192 N SER A 181 SHEET 3 AA9 4 THR A 202 TYR A 207 -1 O SER A 204 N CYS A 193 SHEET 4 AA9 4 ARG A 210 GLY A 216 -1 O ILE A 215 N ALA A 203 SHEET 1 AB1 3 LEU A 223 ARG A 224 0 SHEET 2 AB1 3 THR A 236 GLY A 244 -1 O THR A 242 N ARG A 224 SHEET 3 AB1 3 VAL A 231 ILE A 233 -1 N ILE A 233 O THR A 236 SHEET 1 AB2 4 LEU A 223 ARG A 224 0 SHEET 2 AB2 4 THR A 236 GLY A 244 -1 O THR A 242 N ARG A 224 SHEET 3 AB2 4 ALA A 250 GLU A 258 -1 O ILE A 257 N CYS A 237 SHEET 4 AB2 4 LYS A 261 PRO A 267 -1 O SER A 266 N ILE A 254 SHEET 1 AB3 4 GLU A 276 ARG A 283 0 SHEET 2 AB3 4 GLY A 286 ARG A 292 -1 O ARG A 288 N TYR A 281 SHEET 3 AB3 4 PRO A 301 ASN A 306 -1 O ILE A 305 N VAL A 287 SHEET 4 AB3 4 SER A 311 TYR A 316 -1 O SER A 315 N ILE A 302 SHEET 1 AB4 4 TRP A 352 ASP A 356 0 SHEET 2 AB4 4 ASP A 359 ARG A 364 -1 O TRP A 361 N PHE A 354 SHEET 3 AB4 4 SER A 372 VAL A 379 -1 O GLU A 375 N ARG A 364 SHEET 4 AB4 4 GLN A 391 ARG A 403 -1 O GLN A 395 N THR A 376 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 2 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 3 CYS A 92 CYS A 417 1555 1555 2.03 SSBOND 4 CYS A 124 CYS A 129 1555 1555 2.03 SSBOND 5 CYS A 175 CYS A 193 1555 1555 2.03 SSBOND 6 CYS A 183 CYS A 230 1555 1555 2.03 SSBOND 7 CYS A 232 CYS A 237 1555 1555 2.03 SSBOND 8 CYS A 278 CYS A 291 1555 1555 2.03 SSBOND 9 CYS A 280 CYS A 289 1555 1555 2.03 SSBOND 10 CYS A 318 CYS A 337 1555 1555 2.03 SSBOND 11 CYS A 421 CYS A 447 1555 1555 2.03 LINK ND2 ASN A 146 C1 NAG A 502 1555 1555 1.44 LINK ND2 ASN A 200 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN A 234 C1 NAG A 504 1555 1555 1.44 LINK ND2 ASN A 329 C1 NAG A 503 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.44 LINK O3 BMA B 3 C1 MAN B 4 1555 1555 1.44 LINK O2 MAN B 4 C1 MAN B 5 1555 1555 1.44 CISPEP 1 TYR A 284 PRO A 285 0 4.20 CISPEP 2 THR A 325 PRO A 326 0 3.74 CISPEP 3 ARG A 430 LYS A 431 0 2.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000